Clinical Trials Browser

Withdrawn × Biliary Tract Neoplasms × Irinotecan × Clear all

NCT03110510 2022-06-15

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT02720601 2018-01-25

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms